Aeglea Biotherapeutics shares owned by Vanguard Group
Quarter-by-quarter ownership of Aeglea Biotherapeutics (SYRE) shares owned by Vanguard Group
from 13F filings
Historical chart of Vanguard Group investment in Aeglea Biotherapeutics
Tip: Access up to 7 years of quarterly data
All positions including Aeglea Biotherapeutics held by Vanguard Group consolidated in one spreadsheet with up to 7 years of data
Download as csv
Download as Excel
Quarterly reported holdings in Aeglea Biotherapeutics by Vanguard Group
| Quarter filed | Position value | Share count | Share price at filing |
|---|---|---|---|
| 2024-03-31 | $19M | 497k | 37.93 |
| 2023-12-31 | $849k | 39k | 21.52 |
| 2023-09-30 | $405k | 33k | 12.25 |